{"id":839,"date":"2013-01-31T12:41:02","date_gmt":"2013-01-31T12:41:02","guid":{"rendered":"https:\/\/asfema.org\/blog\/?p=839"},"modified":"2017-05-14T09:50:36","modified_gmt":"2017-05-14T09:50:36","slug":"lista-de-medicamentos-que-contienen-aspartamo-actualizada-a-enero-de-2013","status":"publish","type":"post","link":"https:\/\/asfema.org\/blog\/index.php\/lista-de-medicamentos-que-contienen-aspartamo-actualizada-a-enero-de-2013\/","title":{"rendered":"Lista de Medicamentos que contienen Aspartamo actualizada a enero de 2013"},"content":{"rendered":"<p>Como ya sab\u00e9is, algunos medicamentos contienen aspartamo, un edulcorante con base de fenilalanina que no pueden ingerir los afectados por metabolopat\u00edas.<\/p>\n<p>Os dejamos la lista actualizada de medicamentos sin aspartamo, actualizada a 2013 en un PDF para que os lo pod\u00e1is descargar e imprimir:\u00a0<a href=\"https:\/\/asfema.org\/blog\/index.php\/lista-de-medicamentos-que-contienen-aspartamo-actualizada-a-enero-de-2013\/201301_llistat-alfabetic-castella\/\" rel=\"attachment wp-att-840\">Medicamentos con Aspartamos en 2013<\/a>.<\/p>\n<p>Fuente: <a title=\"Gu\u00eda Metab\u00f3lica\" href=\"http:\/\/www.guiametabolica.org\/consejo\/relacion-de-medicamentos-que-contienen-aspartamo\" target=\"_blank\" rel=\"noopener noreferrer\">Gu\u00eda Metab\u00f3lica<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Como ya sab\u00e9is, algunos medicamentos contienen aspartamo, un edulcorante con base de fenilalanina que no pueden ingerir los afectados por metabolopat\u00edas. Os dejamos la lista actualizada de medicamentos sin aspartamo, actualizada a 2013 en un PDF para que os lo pod\u00e1is descargar e imprimir:\u00a0Medicamentos con Aspartamos en 2013. Fuente: Gu\u00eda Metab\u00f3lica.<\/p>\n","protected":false},"author":1,"featured_media":3053,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"categories":[5,1],"tags":[124,122,123,40],"acf":[],"_links":{"self":[{"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/posts\/839"}],"collection":[{"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/comments?post=839"}],"version-history":[{"count":2,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/posts\/839\/revisions"}],"predecessor-version":[{"id":3138,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/posts\/839\/revisions\/3138"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/media\/3053"}],"wp:attachment":[{"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/media?parent=839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/categories?post=839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/tags?post=839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}